Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Solid State NMR Reveals Heat Shock Protein's Molecular Structure

By LabMedica International staff writers
Posted on 26 Oct 2015
A team of German proteomics researchers has established the molecular structure of the small heat shock protein alpha-B-crystallin, a finding that is expected to aid in the search for drugs to treat illnesses such as Alzheimer's disease, which are characterized by toxic protein clumping.

Heat shock proteins (HSP) are a family of proteins—of which alpha-B-crystallin is a member—that are produced by cells in response to exposure to stressful conditions. More...
They were first described in relation to heat shock, but are now known to also be expressed during other types of stress including exposure to cold, UV light, and during wound healing or tissue remodeling. Many members of this group perform a chaperone function by stabilizing new proteins to ensure correct folding or by helping to refold proteins that were damaged by cell stress.

Mechanistic details of human alpha-B-crystallin, particularly in its client-bound state, have been difficult to obtain, owing to the high molecular weight and the heterogeneity of these complexes.

Investigators at the Technical University of Munich (Germany) and the Helmholtz Zentrum Muenchen (Munich, Germany) used state-of-the-art solid-state NMR (nuclear magnetic resonance) spectroscopy to study the structure of alpha-B-crystallin bound to Alzheimer's disease Abeta1–40 peptide and, in a separate study, to the enzyme lysozyme.

They reported in the October 12, 2015, online edition of the journal Nature Structural Molecular Biology that the alpha-B-crystallin complex was assembled from asymmetric building blocks. Interaction studies demonstrated that the fibril-forming Alzheimer's disease Abeta1–40 peptide preferentially bound to a hydrophobic edge of the central beta-sandwich of alpha-B-crystallin. In contrast, the amorphously aggregating client lysozyme was captured by the partially disordered N-terminal domain of alpha-B-crystallin. These results implied that alpha-B-crystallin used its inherent structural plasticity to expose distinct binding interfaces and thus interact with a wide range of structurally variable clients.

Senior author Dr. Bernd Reif, professor of chemistry at the Technical University of Munich, said, "Alpha-B-crystallin exists in various different forms comprising 24, 28, or 32 subunits that are permanently being swapped. In addition, it has a large molecular weight. These factors make structure analysis very difficult."

Related Links:

Technical University of Munich
Helmholtz Zentrum Muenchen



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.